| Cat. No. | Product Name | Information | 
            
                
            	| PC-24703 | KIN-8741 c-Met inhibitor | KIN-8741 is a potent, selective type IIb c-Met kinase inhibitor with IC50 of 11 nM for both WT and D1228 N c-Met in cell viability assays utilized engineered Ba/F3-TPR-c-Met-WT and Ba/F3-TPR-c-Met-D1228N. | 
            
                
            	| PC-21636 | Ningetinib MET/AXL inhibitor | Ningetinib (CT053PTSA) is a potent, orally bioavailable multikinase inhibitor against c-Met, VEGFR2 as well as Axl, Mer, and FLT3, shows IC50s of 6.7, 1.9 and < 1.0 nM against c-Met, VEGFR-2 and Axl in cell-based assays. | 
            
                
            	| PC-20461 | Tepotinib MET inhibitor | Tepotinib (EMD1214063, MSC2156119) is a potent, specific and ATP-competitive inhibitor of MET (HGFR) with IC50 of 23 nM for MET WT autophosphorylation and 2.2-42.6 nM for M1268T, Y1248H, H1112Y, L1213V, H1112L, V1110I, V1206L, and V1238I MET-mutated variants. | 
            
                
            	| PC-20333 | Merestinib c-Met inhibitor | Merestinib (LY2801653) is a potent, selective, type-II ATP competitive inhibitor of c-Met with Ki of 2 nM, inhibits c-MET wt and mutant Y1230C with IC50 of 42 and 54 nM, respectively. | 
            
                
            	| PC-20053 | BAY-474 c-Met inhibitor | BAY-474 (BAY474) is a potent selective inhibitor of c-MET (Tyrosine-protein Kinase Met) with IC50 of <1 nM. | 
            
                
            	| PC-49518 | SYN1143 c-Met/Ron inhibitor | SYN1143 (AMG-1) is a potent specific small molecule inhibitor of c-Met kinase and RON with IC50 of 4 and 9 nM, inhibits c-Met signaling and cell proliferation in vitro. | 
            
                
            	| PC-49517 | OSI-296 c-Met/Ron inhibitor | OSI-296 is a potent and selective inhibitor of c-MET and RON kinases with cellular IC50 of 42 and 200 nM, respectively. | 
            
                
            	| PC-49516 | LCRF-0004 Ron kinase inhibitor | LCRF-0004 is a potent and selective RON receptor tyrosine kinase inhibitor with IC50 of 50 nM (ELISA), weakly inhibits c-Met with IC50 of 150 nM and does not inhibit VEGFR2. | 
            
                
            	| PC-49513 | XL092 VEGFR/MET/TAM inhibitor | XL092 (XL-092) is a novel small molecule multi-receptor tyrosine kinase (RTK) inhibitor, targets MET (IC50=3.0 nM), VEGFR2 (IC50=15.0 nM), and the TAM kinases TYRO3, AXL (IC50=5.8 nM), and MER (IC50=0.6 nM). | 
            
                
            	| PC-49451 | D6808 c-MET inhibitor | D6808 is a highly selective and potent macrocyclic c-Met inhibitor with IC50 of 2.9 nM. | 
            
                
            	| PC-49280 | c-MET inhibitor 7 c-MET inhibitor | c-MET inhibitor 7 is a potent, highly selective c-MET inhibitor with IC50 of 0.90 and 0.09 μM for wild-type and D1228V c-MET, respectively. | 
            
                
            	| PC-49132 | Dalmelitinib c-Met inhibitor | Dalmelitinib is a potent, selective c-Met tyrosine kinase inhibitor with IC50 of 0.7 nM, inhibits cell growth of gastric cells SNU5 with IC50 of 2.0 nM, binds to the ATP-binding region of c-MET kinase. |